
Five Prime Therapeutics Inc - Strategic SWOT Analysis Review
Description
Five Prime Therapeutics Inc - Strategic SWOT Analysis Review
- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Five Prime Therapeutics Inc (Five Prime), a subsidiary of Amgen Inc, is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic proteins. The company’s pipeline products include cabiralizumab; Bemarituzumab (FPA144); FPT155; FPA157; and BMS-986258. Five Prime has also developed proprietary protein screening technologies and rapid in vivo protein production system to identify new targets for protein therapeutics. The company has development collaborations with various companies to advance its pipeline products. Five Prime is headquartered in South San Francisco, California, the US.
Five Prime Therapeutics Inc Key Recent Developments
Mar 09,2021: Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call
Mar 05,2021: Amgen signs agreement to acquire Five Prime Therapeutics for $1.9bn
Mar 02,2021: Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call
Feb 26,2021: Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference
Feb 22,2021: Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
Reasons to Buy
- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Five Prime Therapeutics Inc (Five Prime), a subsidiary of Amgen Inc, is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic proteins. The company’s pipeline products include cabiralizumab; Bemarituzumab (FPA144); FPT155; FPA157; and BMS-986258. Five Prime has also developed proprietary protein screening technologies and rapid in vivo protein production system to identify new targets for protein therapeutics. The company has development collaborations with various companies to advance its pipeline products. Five Prime is headquartered in South San Francisco, California, the US.
Five Prime Therapeutics Inc Key Recent Developments
Mar 09,2021: Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call
Mar 05,2021: Amgen signs agreement to acquire Five Prime Therapeutics for $1.9bn
Mar 02,2021: Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call
Feb 26,2021: Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference
Feb 22,2021: Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
28 Pages
- Section 1 - About the Company
- Five Prime Therapeutics Inc - Key Facts
- Five Prime Therapeutics Inc - Key Employees
- Five Prime Therapeutics Inc - Key Employee Biographies
- Five Prime Therapeutics Inc - Major Products and Services
- Five Prime Therapeutics Inc - History
- Five Prime Therapeutics Inc - Locations And Subsidiaries
- Head Office
- Section 2 – Company Analysis
- Company Overview
- Five Prime Therapeutics Inc - Business Description
- Five Prime Therapeutics Inc - Corporate Strategy
- Five Prime Therapeutics Inc - SWOT Analysis
- SWOT Analysis - Overview
- Five Prime Therapeutics Inc - Strengths
- Five Prime Therapeutics Inc - Weaknesses
- Five Prime Therapeutics Inc - Opportunities
- Five Prime Therapeutics Inc - Threats
- Five Prime Therapeutics Inc - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
- Five Prime Therapeutics Inc, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Mar 09, 2021: Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call
- Mar 02, 2021: Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call
- Feb 26, 2021: Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference
- Feb 22, 2021: Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Five Prime Therapeutics Inc, Key Facts
- Five Prime Therapeutics Inc, Key Employees
- Five Prime Therapeutics Inc, Key Employee Biographies
- Five Prime Therapeutics Inc, Major Products and Services
- Five Prime Therapeutics Inc, History
- Five Prime Therapeutics Inc, Key Competitors
- Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
- Five Prime Therapeutics Inc, Recent Deals Summary
- List of Figures
- Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
- Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.